Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical Breast Cancer|March 27, 2012
Quality of life in long-term survivors of metastatic breast cancerJane L Meisel, Susan M Domchek, Robert H Vonderheide, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 8, 2023
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot studyGelareh Sadigh, Jane L Meisel, Kristina Byers, et al.Breast Cancer Research and Treatment|November 27, 2016
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancerXiaoxian Li, Jing Yang, Limin Peng, et al.Clinical Breast Cancer|January 19, 2025
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 StudyShari B Goldfarb, Sarah L Sammons, Jane L Meisel, et al.Annals of Surgical Oncology|December 10, 2024
Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical DataMarie L Fefferman, Danielle M Thompson, Lee G Wilke, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 8, 2019
The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing TerminologyBrianna A McDaniels, Rachel S Hianik, Cecelia Bellcross, et al.Springerplus|July 27, 2013
Contemporary multidisciplinary treatment of pregnancy-associated breast cancerJane L Meisel, Katherine E Economy, Katherina Zabicki Calvillo, et al.Clinical Breast Cancer|December 7, 2019
Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast CancerJane L Meisel, Jing Zhao, Aili Suo, et al.American Journal of Clinical Pathology|October 1, 2016
Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast CancerXiaoxian Li, Ceyda Sonmez Wetherilt, Uma Krishnamurti, et al.Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.Pageof 4